Personalis, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Personalis, Inc. (PSNL) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-02-27
- Personalis, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $0.00.
- Personalis, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00.
- Personalis, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was $0.00.
- Personalis, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Personalis, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Personalis, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $1.30M, a 58.06% decline from fiscal 2022.
- Personalis, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $3.10M, a 93.33% decline from fiscal 2021.
- Personalis, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $46.50M, a 374.49% increase from fiscal 2020.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $1.30M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.30M 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $1.30M 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.10M derived: sum of 2 quarters · filed 2024-02-28 | $3.10M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.10M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $44.80M derived: sum of 2 quarters · filed 2024-02-28 | $46.50M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $44.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $46.40M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $1.70M 10-Q · filed 2022-08-03 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $9.80M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $9.80M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $9.80M 10-Q · filed 2021-08-04 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.10M derived: sum of 2 quarters · filed 2022-02-24 | $2.80M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.80M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $1.70M 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |